MedPath

A Study of Ivermectin Lotion 0.5% w/w for the Treatment of Pediculus humanus capitis (head lice) Infestation

Phase 3
Not yet recruiting
Conditions
Other specified local infections of the skin and subcutaneous tissue,
Registration Number
CTRI/2018/10/016125
Lead Sponsor
Ajanta Pharma Ltd
Brief Summary

A  Comparative, Two arm, Randomized, Double blind,Parallel Group, Vehicle Controlled Clinical Study to Evaluate Efficacy andSafety of Ivermectin Lotion 0.5% w/w for the Treatment of *Pediculus humanus capitis* (head lice) Infestation

 PrimaryObjective: To evaluate the efficacy of Ivermectin Lotion 0.5% w/wVersus Vehicle Control in lice infested subjects.

 SecondaryObjective: To evaluate the safety of Ivermectin Lotion 0.5% w/wVersus Vehicle Control in lice infested subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
219
Inclusion Criteria
  • Subjects meeting all of the following criteria will be recruited for the trial: 1.Healthy males, non-pregnant females and children of age ≥6 months to ≤65 years (both inclusive) will be enrolled.
  • 2.Subjects must have an active head lice infestation of atleast three live lice and/or viable nits.
  • (Viability of nits to be determined by using magnifying lens at a distance of less than 0.6 cm/6 mm from the scalp).
  • 3.Following application and rinsing of the test article, subject agrees not to shampoo, wash, or rinse their hair or scalp until the 24 hour post treatment evaluation has been completed.
  • 4.Subject agrees not to cut or chemically treat their hair while participating in the study.
  • 5.Subject and/or parent/guardian agree that the subject will not use any other form of lice treatment during the duration of the study.
  • 6.Subjects who are willing to sign informed consent for participation in the study and willing to adhere to all protocol procedures.
  • Caregivers who are willing to sign Informed Consent agreement for children of age <7 years.
  • Children of age ≥7 years who are willing to sign a child’s assent form.
Exclusion Criteria
  • Subjects will be excluded if ANY of the following conditions apply: 1.Female subjects who are pregnant or lactating or planning to become pregnant during the study period.
  • Females who are not ready to use acceptable contraceptive methods during the course of study.
  • 2.Scalp condition that could make it difficult to evaluate the extent and severity of an infestation or that would present a problem in the evaluation of response to therapy (e.g. psoriatic scalp lesions, extensive seborrheic dermatitis).
  • 3.Treatment for head lice (OTC, home remedy and/or prescription drugs) in the last 7 days.
  • 4.Subject who used any hair dye, bleaches, hair straightening or permanent wave solution on the hair within 14 days of randomization.
  • 5.Known history of irritation or sensitivity to pediculicides or hair care products.
  • 6.Subjects with known allergy or hypersensitivity to Ivermectin or any component of the test product.
  • 7.Any condition or illness that may compromise the objective of the protocol.
  • 8.Subject receiving any other treatment which may interfere with the study results.
  • 9.Participation in a previous investigational drug study within the past 30 days.
  • 10.Does not understand the requirements for study participation and/or may likely exhibit poor compliance.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Ivermectin Lotion 0.5% w/w Versus Vehicle Control in lice infested subjects.at the end of 2 weeks
Secondary Outcome Measures
NameTimeMethod
To evaluate the safety of Ivermectin Lotion 0.5% w/w Versus Vehicle Control in lice infested subjectsat the end of 2 weeks

Trial Locations

Locations (16)

Christian Medical College Ludhiana

🇮🇳

Ludhiana, PUNJAB, India

Department of Dermatology TN Medical College & BYL Nair Ch. Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

Department of Skin and VD Indira Gandhi Institute of Medical Sciences

🇮🇳

Patna, BIHAR, India

Down Town Hospital Ltd

🇮🇳

Jorhat, ASSAM, India

G T Hospital, Grant Government Medical College & Sir J.J. Group of Hospital

🇮🇳

Mumbai, MAHARASHTRA, India

Gandhi Hospital

🇮🇳

Hyderabad, ANDHRA PRADESH, India

GCS Medical College, Hospital and Research Centre

🇮🇳

Ahmadabad, GUJARAT, India

GMERS Medical College and Civil Hospital Sola

🇮🇳

Ahmadabad, GUJARAT, India

GSVM Medical College

🇮🇳

Nagar, UTTAR PRADESH, India

Jeevan Jyoti Multispecialty Hospital & Research Centre

🇮🇳

Allahabad, UTTAR PRADESH, India

Scroll for more (6 remaining)
Christian Medical College Ludhiana
🇮🇳Ludhiana, PUNJAB, India
Dr Bimal Kanish
Principal investigator
919814101367
drbimalkanish@yahoo.co.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.